Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Pavlicek

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Genome Research|January 15, 2009
Human gamma-satellite DNA maintains open chromatin structure and protects a transgene from epigenetic silencingJung-Hyun Kim, Thomas Ebersole, Natalay Kouprina, et al.
Molecular Cancer Therapeutics|October 11, 2013
Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871)Adam Pavlicek, Maruja E Lira, Nathan V Lee, et al.
Molecular Cancer Therapeutics|January 7, 2012
An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735Kenneth E Hook, Scott J Garza, Maruja E Lira, et al.
Plos One|April 5, 2007
Evolutionary diversification of SPANX-N sperm protein gene structure and expressionNatalay Kouprina, Vladimir N Noskov, Adam Pavlicek, et al.
Human Molecular Genetics|June 24, 2005
The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle proteinNatalay Kouprina, Adam Pavlicek, N Keith Collins, et al.
Nature Communications|September 14, 2019
Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney diseaseEdmund C Lee, Tania Valencia, Charles Allerson, et al.
Lancet (London, England)|January 15, 2017
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trialMeike H van der Ree, J Marleen de Vree, Femke Stelma, et al.
Molecular Cancer Research : MCR|March 12, 2015
Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network DeregulationTimothy R Wagenaar, Sonya Zabludoff, Sung-Min Ahn, et al.
Nature Medicine|October 10, 2022
Anti-tumor efficacy of a potent and selective non-covalent KRAS<sup>G12D</sup> inhibitorJill Hallin, Vickie Bowcut, Andrew Calinisan, et al.
Cancer Discovery|October 30, 2019
The KRAS<sup>G12C</sup> Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and PatientsJill Hallin, Lars D Engstrom, Lauren Hargis, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Genome Research|January 15, 2009
Human gamma-satellite DNA maintains open chromatin structure and protects a transgene from epigenetic silencingJung-Hyun Kim, Thomas Ebersole, Natalay Kouprina, et al.
Molecular Cancer Therapeutics|October 11, 2013
Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871)Adam Pavlicek, Maruja E Lira, Nathan V Lee, et al.
Molecular Cancer Therapeutics|January 7, 2012
An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735Kenneth E Hook, Scott J Garza, Maruja E Lira, et al.
Plos One|April 5, 2007
Evolutionary diversification of SPANX-N sperm protein gene structure and expressionNatalay Kouprina, Vladimir N Noskov, Adam Pavlicek, et al.
Human Molecular Genetics|June 24, 2005
The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle proteinNatalay Kouprina, Adam Pavlicek, N Keith Collins, et al.
Nature Communications|September 14, 2019
Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney diseaseEdmund C Lee, Tania Valencia, Charles Allerson, et al.
Lancet (London, England)|January 15, 2017
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trialMeike H van der Ree, J Marleen de Vree, Femke Stelma, et al.
Molecular Cancer Research : MCR|March 12, 2015
Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network DeregulationTimothy R Wagenaar, Sonya Zabludoff, Sung-Min Ahn, et al.
Nature Medicine|October 10, 2022
Anti-tumor efficacy of a potent and selective non-covalent KRAS<sup>G12D</sup> inhibitorJill Hallin, Vickie Bowcut, Andrew Calinisan, et al.
Cancer Discovery|October 30, 2019
The KRAS<sup>G12C</sup> Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and PatientsJill Hallin, Lars D Engstrom, Lauren Hargis, et al.
Pageof 3